1st FDA-funded DMD Study Now Recruiting Patients to Test Ifetroban

1st FDA-funded DMD Study Now Recruiting Patients to Test Ifetroban

304082

1st FDA-funded DMD Study Now Recruiting Patients to Test Ifetroban

Cumberland Pharmaceuticals is recruiting boys and men for a Phase 2 study evaluating the safety, efficacy, and duration of effect of its oral ifetroban therapy for cardiomyopathy — a disease of the heart muscle — linked to Duchenne muscular dystrophy (DMD). The study, called FIGHT DMD (NCT03340675), is looking to enroll 48 Duchenne patients, ages 7 and older, from various locations across the U.S. Their heart and lung function, muscle strength, daily activity, and quality…

You must be logged in to read/download the full post.